Pfizer completes acquisition of Metsera
MLex Summary: Pharmaceutical giant Pfizer announced the completion of its acquisition of Metsera, a clinical-stage biopharmaceutical company that makes medicines for obesity and cardiometabolic diseases.Statement follows in full....To view the full article, register now.
Already a subscriber? Click here to view full article